What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
Hongbing Shen spends much of his time researching Genetics, Genome-wide association study, Internal medicine, Genotype and Cancer.
His Genetics research is multidisciplinary, relying on both Meta-analysis and Lung cancer.
His biological study spans a wide range of topics, including Polymorphism, Genetic predisposition, Han chinese, Genetic association and Locus.
The study incorporates disciplines such as Gastroenterology, Oncology and Pathology in addition to Internal medicine.
He interconnects Odds ratio, Case-control study and Risk factor in the investigation of issues within Genotype.
Hongbing Shen studied Cancer and Immunology that intersect with Gene silencing.
His most cited work include:
- Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. (700 citations)
- Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung Cancer (654 citations)
- Genetic variants of miRNA sequences and non-small cell lung cancer survival. (500 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Single-nucleotide polymorphism, Genetics, Oncology and Lung cancer.
His study in Internal medicine is interdisciplinary in nature, drawing from both Genotype and Bioinformatics.
His work is dedicated to discovering how Single-nucleotide polymorphism, Hepatocellular carcinoma are connected with Hepatitis B virus and other disciplines.
His Oncology research integrates issues from microRNA, Proportional hazards model, Hazard ratio, Stage and Breast cancer.
His work deals with themes such as Cancer research, Carcinogenesis, Immunology, Lung cancer susceptibility and Adenocarcinoma, which intersect with Lung cancer.
His Genome-wide association study research is multidisciplinary, incorporating elements of Genetic association and Locus.
He most often published in these fields:
- Internal medicine (41.43%)
- Single-nucleotide polymorphism (32.95%)
- Genetics (31.95%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (41.43%)
- Lung cancer (26.62%)
- Genome-wide association study (25.79%)
In recent papers he was focusing on the following fields of study:
Hongbing Shen mostly deals with Internal medicine, Lung cancer, Genome-wide association study, Genetic association and Oncology.
His research on Internal medicine frequently links to adjacent areas such as Gastroenterology.
His Lung cancer study incorporates themes from Genetic predisposition, Carcinogenesis, Adenocarcinoma, Lung and Risk factor.
Hongbing Shen has included themes like Genetic correlation, Transcriptome, Genetic risk, Meta-analysis and Genetic heterogeneity in his Genome-wide association study study.
Single-nucleotide polymorphism, Genetics and Gene are the areas that his Genetic association study falls under.
The Oncology study which covers Mendelian randomization that intersects with Mendelian Randomization Analysis.
Between 2018 and 2021, his most popular works were:
- Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. (700 citations)
- Shared heritability and functional enrichment across six solid cancers (41 citations)
- A cancer-testis non-coding RNA LIN28B-AS1 activates driver gene LIN28B by interacting with IGF2BP1 in lung adenocarcinoma (38 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Hongbing Shen mainly investigates Internal medicine, Genome-wide association study, Oncology, Genetic association and Cancer.
The various areas that Hongbing Shen examines in his Genome-wide association study study include Genetic correlation, Meta-analysis, Breast cancer, Colorectal cancer and Prostate cancer.
Hongbing Shen studies Lung cancer which is a part of Oncology.
He's looking at Genetic association as part of his Genetics and Single-nucleotide polymorphism and Genetic association study.
Particularly relevant to Lung cancer susceptibility is his body of work in Genetics.
His Cancer study integrates concerns from other disciplines, such as Regulation of gene expression, CpG site and Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
